Evidence map›Paper›PMID 9777947›Full record

ArticleThe American journal of pathology1998

Effects of growth factors and basement membrane proteins on the phenotype of U-373 MG glioblastoma cells as determined by the expression of intermediate filament proteins.

S Sultana, R Zhou, M S Sadagopan, O Skalli

Abstract read
In one paragraph

Article in The American journal of pathology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 26 citations in OpenAlex.

  1. Structural changes in intermediate filament networks alter the activity of insulin-degrading enzyme.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2009
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

S SultanaDepartment of Anatomy and Cell Biology, University of Illinois at Chicago, 60612, USA.
R Zhou
M S Sadagopan
O Skalli
University of Illinois Chicago · US

Funding

GLIAL FILAMENT ASSOCIATED PROTEINS IN HUMAN ASTROCYTOMASR01NS035317 · NINDS · LOUISIANA STATE UNIV HSC SHREVEPORT · PI SKALLI, OMAR · 2003 to 2006
$959k
GLIAL FILAMENT ASSOCIATED PROTEINS IN HUMAN ASTROCYTOMASR29NS035317 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SKALLI, OMAR · 1996 to 2000
$111k
NINDS NIH HHS NS-35317NINDS NIH HHS R01 NS035317NINDS NIH HHS R29 NS035317
6 · The paper itself

Abstract

Various growth factors and basement membrane proteins have been implicated in the pathobiology of astrocytomas. The goal of this study was to determine the relative contribution of these two factors in modulating the phenotype of U-373 MG glioblastoma cells as determined by the expression of the intermediate filament proteins glial fibrillary acidic protein, vimentin, and nestin. For these determinations, cells plated in serum-free medium were treated either with growth factors binding to tyrosine kinase receptors including transforming growth factor-alpha, epidermal growth factor, platelet-derived growth factor-AA, basic fibroblast growth factor, and insulin-like growth factor-1 or with basement membrane proteins including collagen IV, laminin, and fibronectin. The changes in the expression levels of intermediate filament proteins in response to these treatments were analyzed by quantitation of immunoblots. The results demonstrate that collagen IV and growth factors binding to tyrosine kinase receptors decrease the glial fibrillary acidic protein content of U-373 MG cells. Growth factors binding to tyrosine kinase receptors also decrease the vimentin content of these cells but do not affect their nestin content. On the other hand, basement membrane proteins decrease the nestin content of U-373 MG cells but do not affect their vimentin content. The significance of these results with respect to the role played by different factors in modulating the phenotype of neoplastic astrocytes during tumor progression is discussed.

Indexed as

Basement MembraneBrain NeoplasmsCell Transformation, NeoplasticFluorescent Antibody Technique, IndirectGlioblastomaGrowth SubstancesHumansImmunoblottingIntermediate Filament ProteinsMembrane ProteinsPhenotypeReceptor Protein-Tyrosine KinasesTumor Cells, CulturedGrowth SubstancesIntermediate Filament ProteinsMembrane ProteinsReceptor Protein-Tyrosine Kinases

Identifiers

PMID9777947
PMCPMC1853038
OpenAlexW2059096976

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.